BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7540931)

  • 1. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis.
    Connop BP; Boegman RJ; Jhamandas K; Beninger RJ
    Brain Res; 1995 Apr; 676(1):124-32. PubMed ID: 7540931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase.
    Connop BP; Boegman RJ; Beninger RJ; Jhamandas K
    Neuropharmacology; 1996 Apr; 35(4):459-65. PubMed ID: 8793908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole.
    Connop BP; Rolfe NG; Boegman RJ; Jhamandas K; Beninger RJ
    Neuropharmacology; 1994 Nov; 33(11):1439-45. PubMed ID: 7532827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of quinolinic acid-induced depletion of striatal NADPH diaphorase and enkephalinergic neurons by inhibition of nitric oxide synthase.
    Kalisch BE; Jhamandas K; Beninger RJ; Boegman RJ
    Brain Res; 1999 Jan; 817(1-2):151-62. PubMed ID: 9889356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
    Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
    Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia.
    Buisson A; Margaill I; Callebert J; Plotkine M; Boulu RG
    J Neurochem; 1993 Aug; 61(2):690-6. PubMed ID: 7687658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual role for nitric oxide in NMDA-mediated toxicity in vivo.
    Globus MY; Prado R; Sanchez-Ramos J; Zhao W; Dietrich WD; Busto R; Ginsberg MD
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):904-13. PubMed ID: 7593350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of intrastriatal co-administration of L-NAME and quinolinic acid.
    Galasso JM; Bazzett TJ; Becker JB; Albin RL
    Neuroreport; 1995 Jul; 6(11):1505-8. PubMed ID: 7579135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine modulates N-methyl-D-aspartate-stimulated hippocampal nitric oxide production in vivo.
    Bhardwaj A; Northington FJ; Koehler RC; Stiefel T; Hanley DF; Traystman RJ
    Stroke; 1995 Sep; 26(9):1627-33. PubMed ID: 7544925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity.
    Pérez-Severiano F; Escalante B; Ríos C
    Neurochem Res; 1998 Oct; 23(10):1297-302. PubMed ID: 9804286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nitric oxide availability on responses of spinal wide dynamic range neurons to excitatory amino acids.
    Budai D; Wilcox GL; Larson AA
    Eur J Pharmacol; 1995 May; 278(1):39-47. PubMed ID: 7545123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum.
    MacKenzie GM; Jenner P; Marsden CD
    Neuroscience; 1995 Jul; 67(2):357-71. PubMed ID: 7545792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats.
    Malmberg AB; Yaksh TL
    Pain; 1993 Sep; 54(3):291-300. PubMed ID: 8233543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.
    Salter M; Duffy C; Hazelwood R
    Neuropharmacology; 1995 Mar; 34(3):327-34. PubMed ID: 7543191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory action of N-methyl-D-aspartate on the rat locus coeruleus is mediated by nitric oxide: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1998 Jun; 796(1-2):176-86. PubMed ID: 9689468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomega-nitro-L-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices.
    Santamaría D; Espinoza-González V; Ríos C; Santamaría A
    Neurochem Res; 1999 Jul; 24(7):843-8. PubMed ID: 10403623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats.
    Maragos WF; Silverstein FS
    J Neurochem; 1995 May; 64(5):2362-5. PubMed ID: 7536812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.
    Gomes MZ; Raisman-Vozari R; Del Bel EA
    Brain Res; 2008 Apr; 1203():160-9. PubMed ID: 18313645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium and zinc potentiate ethanol inhibition of N-methyl-D-aspartate-stimulated nitric oxide synthase in cortical neurons.
    Chandler LJ; Guzman NJ; Sumners C; Crews FT
    J Pharmacol Exp Ther; 1994 Oct; 271(1):67-75. PubMed ID: 7525932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthesis inhibits rat sleep.
    Kapás L; Fang J; Krueger JM
    Brain Res; 1994 Nov; 664(1-2):189-96. PubMed ID: 7534601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.